36 related articles for article (PubMed ID: 20205165)
1. Fibroblasts Derived From Vestibular Schwannoma Express Protumorogenic Markers.
Baruah P; Marshall J; Jones PN; Major T; Pucino V; O'Neil JD; Nefla M; McGettrick H; Monksfield P; Irving R; Buckley CD
Otol Neurotol; 2023 Dec; 44(10):e755-e765. PubMed ID: 37733967
[TBL] [Abstract][Full Text] [Related]
2. Identifying Tumor Microenvironment Biomarkers in Adherent and Cystic Vestibular Schwannomas.
Zhang L; Kuo HC; Duhon BH; Adunka OF; Dodson EE; Hardesty DA; Prevedello DM; Otero JJ; Ren Y
Otol Neurotol; 2024 Feb; 45(2):e113-e122. PubMed ID: 38082472
[TBL] [Abstract][Full Text] [Related]
3. Schwannomas of Brain and Spinal Cord.
Gerganov V; Petrov M; Sakelarova T
Adv Exp Med Biol; 2023; 1405():331-362. PubMed ID: 37452944
[TBL] [Abstract][Full Text] [Related]
4. Perfusion-weighted imaging in vestibular schwannoma: the influence that cystic status and tumor size have on perfusion profiles.
Constanzo F; Teixeira BCA; Sens P; Smaili H; Escuissato DL; Ramina R
Radiol Bras; 2023; 56(2):67-74. PubMed ID: 37168041
[TBL] [Abstract][Full Text] [Related]
5. Tumor Microenvironment in Sporadic Vestibular Schwannoma: A Systematic, Narrative Review.
Cazzador D; Astolfi L; Daloiso A; Tealdo G; Simoni E; Mazzoni A; Zanoletti E; Marioni G
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047498
[TBL] [Abstract][Full Text] [Related]
6. Tumor Biology and Microenvironment of Vestibular Schwannoma-Relation to Tumor Growth and Hearing Loss.
Tesařová M; Peterková L; Šťastná M; Kolář M; Lacina L; Smetana K; Hynek R; Betka J; Vlasák A; Lukeš P; Fík Z
Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672540
[TBL] [Abstract][Full Text] [Related]
7. Hypervascularized Large Vestibular Schwannomas: Single-Center Experience in a Series of Forty Cases.
Mastronardi L; Campione A; Boccacci F; Scavo CG; Carpineta E; Cacciotti G; Roperto R; Stati G; Liu JK
World Neurosurg X; 2023 Jan; 17():100142. PubMed ID: 36341135
[TBL] [Abstract][Full Text] [Related]
8. Potential Molecular Biomarkers of Vestibular Schwannoma Growth: Progress and Prospects.
Zhang Y; Long J; Ren J; Huang X; Zhong P; Wang B
Front Oncol; 2021; 11():731441. PubMed ID: 34646772
[TBL] [Abstract][Full Text] [Related]
9. Microsurgical treatment of symptomatic vestibular schwannomas in patients under 40: different results before and after age of 30.
Mastronardi L; Campione A; Cacciotti G; Carpineta E; Scavo CG; Roperto R; Stati G; Sufianov AA; Schaller K
Neurosurg Rev; 2022 Feb; 45(1):873-882. PubMed ID: 34405315
[TBL] [Abstract][Full Text] [Related]
10. Koos grade IV vestibular schwannomas: considerations on a consecutive series of 60 cases-searching for the balance between preservation of function and maximal tumor removal.
Mastronardi L; Campione A; Boccacci F; Scavo CG; Carpineta E; Cacciotti G; Roperto R; Sufianov A; Zomorodi A
Neurosurg Rev; 2021 Dec; 44(6):3349-3358. PubMed ID: 33598820
[TBL] [Abstract][Full Text] [Related]
11. MMP-14 (MT1-MMP) Is a Biomarker of Surgical Outcome and a Potential Mediator of Hearing Loss in Patients With Vestibular Schwannomas.
Ren Y; Hyakusoku H; Sagers JE; Landegger LD; Welling DB; Stankovic KM
Front Cell Neurosci; 2020; 14():191. PubMed ID: 32848608
[TBL] [Abstract][Full Text] [Related]
12. Contemporary Molecular Biology of Sporadic Vestibular Schwannomas: A Systematic Review and Clinical Implications.
Sass H; Cayé-Thomasen P
J Int Adv Otol; 2018 Aug; 14(2):322-329. PubMed ID: 30100540
[TBL] [Abstract][Full Text] [Related]
13. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
Wang X; Khalil RA
Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
[TBL] [Abstract][Full Text] [Related]
14. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
Liu J; Khalil RA
Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
[TBL] [Abstract][Full Text] [Related]
15. Perfusion magnetic resonance imaging provides additional information as compared to anatomical imaging for decision-making in vestibular schwannoma.
Kleijwegt MC; van der Mey AG; Wiggers-deBruine FT; Malessy MJ; van Osch MJ
Eur J Radiol Open; 2016; 3():127-33. PubMed ID: 27366777
[TBL] [Abstract][Full Text] [Related]
16. Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.
Saito T; Kasamatsu A; Ogawara K; Miyamoto I; Saito K; Iyoda M; Suzuki T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(9):e0137923. PubMed ID: 26378920
[TBL] [Abstract][Full Text] [Related]
17. Ang II enhances noradrenaline release from sympathetic nerve endings thus contributing to the up-regulation of metalloprotease-2 in aortic dissection patients' aorta wall.
Hu Z; Wang Z; Wu H; Yang Z; Jiang W; Li L; Hu X
PLoS One; 2013; 8(10):e76922. PubMed ID: 24194850
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.
Benjamin MM; Khalil RA
Exp Suppl; 2012; 103():209-79. PubMed ID: 22642194
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis in vestibular schwannomas: expression of extracellular matrix factors MMP-2, MMP-9, and TIMP-1.
Møller MN; Werther K; Nalla A; Stangerup SE; Thomsen J; Bøg-Hansen TC; Nielsen HJ; Cayé-Thomasen P
Laryngoscope; 2010 Apr; 120(4):657-62. PubMed ID: 20205165
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
